With the Asian healthcare market expected to reach more than US$2.6 trillion by 2020, the HealthInvestor Asia Summit brings together major private healthcare players, investors and the industry experts who are all driving innovation in healthcare in Asia.
The event – to be held at Marina Bay Sands in Singapore on 15 May – will focus on how healthcare companies can use the capital markets to their advantage. It provides a single forum to consider the different challenges of healthcare in Asia and how tech and digitalisation are changing the landscape.
The HealthInvestor Asia Summit will feature forensic analysis and spiky debate from chief executives, government officials, investors, financiers and market analysts. It provides a unique opportunity for high-level networking and will give attendees the opportunity to gauge market activity and identify emerging trends.
HealthInvestor Asia (HIA) is the definitive source of financial intelligence for Apac’s growing healthcare markets.
HIA’s dedicated coverage of corporate and capital market activity in the healthcare sector provides independent and authoritative insight for investors, lenders, advisors and healthcare firms operating across the region.
By focusing specifically on the health sector, HIA provides forensic analysis of this vital and growing market.
HIA’s market-leading editorial coverage enables readers to grasp the complexities of the region and follow the flow of investment across health systems in Asia. Its market commentary and analysis is an invaluable tool in identifying trends and opportunities and its focused reporting allows readers to keep up to date with this fast-moving and exciting sector.
Les Lubwama | +44(0)207 104 2006
Shima Nessa | +44(0)207 104 2058
Melissa Mackintosh | +44(0)20 7104 2000